Mitral Valve Prolapse

Braun, W. E., J. Ronan, et al. (1977). “HLA antigens in mitral valve prolapse.” Transplant Proc 9(4): 1869-71. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=601847

Coghlan, H. C. and G. Natello (1991). “Erythrocyte magnesium in symptomatic patients with primary mitral valve prolapse: relationship to symptoms, mitral leaflet thickness, joint hypermobility and autonomic regulation.” Magnes Trace Elem 10(2-4): 205-14. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1844553

Cohen, L., H. Bitterman, et al. (1986). “Idiopathic magnesium deficiency in mitral valve prolapse.” Am J Cardiol 57(6): 486-7. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3946269

Cohen, L., A. Laor, et al. (1988). “Renal excretion of lactate and magnesium in mitral valve prolapse.” Magnes Res 1(1-2): 75-8. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3274927

Devereux, R. B., E. C. Jones, et al. (2001). “Prevalence and correlates of mitral valve prolapse in a population-based sample of American Indians: the Strong Heart Study.” Am J Med 111(9): 679-85. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11747846

Disse, S., E. Abergel, et al. (1999). “Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1.” Am J Hum Genet 65(5): 1242-51. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10521289

Durlach, J. (1994). “Primary mitral valve prolapse: a clinical form of primary magnesium deficit.” Magnes Res 7(3-4): 339-40. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7786696

Durlach, J., P. Bac, et al. (1997). “Neurotic, neuromuscular and autonomic nervous form of magnesium imbalance.” Magnes Res 10(2): 169-95. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9368238

Durlach, J. and V. Durlach (1986). “Idiopathic mitral valve prolapse and magnesium:  state of the art.” Magnesium Bul 8: 156-169
Durlach, J., V. Durlach, et al. (1992). “Magnesium and blood pressure. II. Clinical studies.” Magnes Res 5(2): 147-53. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1390008

Durlach, J., G. Lutfalla, et al. (1985). Latent tetany and mitral valve prolapse due to chronic primary magnesium  deficit. Magnesium Deficiency Physiopathology and Treatment Implications. H. M. J. D. J. Basel, Switzerland, Karger: 102-112

Fauchier, J. P., D. Babuty, et al. (2000). “[Mitral valve prolapse, arrhythmias and sudden death].” Arch Mal Coeur Vaiss 93(12): 1541-7. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11211450

Frances, Y., F. Collet, et al. (1986). “Long-term follow-up of mitral valve prolapse and latent tetany. Preliminary data.” Magnesium 5(3-4): 175-81. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2873272

Galland, L. (1985). Magnesium deficiency in mitral valve prolapse. Magnesium Deficiency Physiopathology and Treatment Implications. M. J. Halpern and J. Durlach. Basel, Switzerland, Karger: 117-119

Galland, L. D., S. M. Baker, et al. (1986). “Magnesium deficiency in the pathogenesis of mitral valve prolapse.” Magnesium 5(3-4): 165-74. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3014234

Gerard, R., R. Luccioni, et al. (1979). “[Mitral valve prolapse and spasmophilia in the adult].” Arch Mal Coeur Vaiss 72(7): 715-20. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=117769

Kachru, R. B., M. Telischi, et al. (1979). “The HLA antigens and ABO blood groups in an American Black population with mitral valve prolapse.” Tissue Antigens 14(3): 256-60. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=524338

Kitlinski, M., E. Konduracka, et al. (2000). “[Evaluation of magnesium cation levels in serum of patients with mitral valve prolapse syndrome].” Folia Med Cracov 41(3-4): 17-24.  https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11339012

Klos, J., B. Lichodziejewska, et al. (1988). “[Results of the compensatory treatment of disorders of magnesium and calcium metabolism in mitral valve prolapse syndrome].” Pol Tyg Lek 43(41): 1330-3. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3244597

Klos, J., B. Lichodziejewska, et al. (1988). “[Disorders of magnesium and calcium metabolism in mitral valve prolapse syndrome].” Pol Tyg Lek 43(41): 1325-9. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3244596

Lichodziejewska, B., J. Klos, et al. (1997). “Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation.” Am J Cardiol 79(6): 768-72. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9070556

Martynov, A. I., O. B. Stepura, et al. (2000). “[New approaches to the treatment of patients with idiopathic mitral valve prolapse].” Ter Arkh 72(9): 67-70.  https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11076423

Simoes Fernandes, J., T. Pereira, et al. (1985). “Therapeutic effect of a magnesium salt in patients suffering from mitral valvular prolapse and latent tetany.” Magnesium 4(5-  6): 283-90. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3914582

Zeana, C., M. Briciu, et al. (1985). “Considerations on the pathogenesis of mitral valve prolapse.” Med Interne 23(3): 165-70. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?   cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=4048797